Expression of fibrosis-associated molecules in IgA nephropathy treated with cyclosporine

Pediatric Nephrology

Volumn 24, Issue 3, 2009, Pages 513-519

  Lim, Beom Jin ^a   Kim, Ji Hong ^b   Hong, Soon Won ^b   Jeong, Hyeon Joo ^b  

^a Chungnam National University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Cyclosporine toxicity; Human; Macrophage; Osteopontin; TGF

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN; CYCLOSPORIN A; IMMUNOGLOBULIN A; OSTEOPONTIN; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ARTICLE; CAPILLARY DENSITY; CELL INFILTRATION; CHILD; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; LONG TERM CARE; LOW DRUG DOSE; MACROPHAGE; MALE; MESANGIUM; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA;

ADOLESCENT; CAPILLARIES; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; FEMALE; FIBROSIS; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 59849127663     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-1055-z     Document Type: Article

References (30)

1. D'Amico G, Imbasciati E, Barbiano Di Belgioioso G, Bertoli S, Fogazzi G, Ferrario F, Fellin G, Ragni A, Colasanti G, Minetti L, Ponticelli C (1985) Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients. Medicine 64:49-60
2. Donadio JV Jr (1991) Omega-3 polyunsaturated fatty acids: A potential new treatment of immune renal disease. Mayo Clin Proc 66:1018-1028
3. Hogg RJ, Fitzgibbons L, Atkins C, Nardelli N, Bay RC (2006) Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent. Clin J Am Soc Nephrol 1:1167-1172
4. Coppo R, Amore A, Peruzzi L, Mancuso D, Camilla R (2007) Angiotensin antagonists and fish oil for treating IgA nephropathy. Contrib Nephrol 157:27-36
5. Locatelli F, Del Vecchio L, Pozzi C (1999) The patient with IgA glomerulonephritis - what is the role of steroid treatment? Nephrol Dial Transplant 14:1057-1060
6. Lai KN, Mac-Moune Lai F, Vallance-Owen J (1988) A short-term controlled trial of cyclosporine A in IgA nephropathy. Transplant Proc 20[Suppl 4]:297-303
7. Kim PK, Kim KS, Pai KS, Kim JH, Choi IJ (1997) Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children. Yonsei Med J 38:307-318
8. Chábová V, Tesar V, Zabka J, Rychlik I, Merta M, Jirsa M, Stejskalová A (2000) Long term treatment of IgA nephropathy with cyclosporine A. Ren Fail 22:55-62
9. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F (2001) Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60:1645-1657
10. Young BA, Burdmann EA, Johnson RJ, Alpers CE, Giachelli CM, Eng E, Andoh T, Bennett WM, Couser WG (1995) Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 48:439-448
11. Thomas SE, Andoh TF, Pichler RH, Shankland SJ, Couser WG, Bennett WM, Johnson RJ (1998) Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 53:897-908
12. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG, Johnson RJ (1995) Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196
13. Lim BJ, Kim PK, Hong SW, Jeong HJ (2004) Osteopontin expression and microvascular injury in cyclosporine nephrotoxicity. Pediatr Nephrol 19:288-294
14. Hudkins KL, Le QC, Segerer S, Johnson RJ, Davis CL, Giachelli CM, Alpers CE (2001) Osteopontin expression in human cyclosporine toxicity. Kidney Int 60:635-640
15. Okada H, Moriwaki K, Konishi K, Kobayashi T, Sugahara S, Nakamoto H, Saruta T, Suzuki H (2000) Tubular osteopontin expression in human glomerulonephritis and renal vasculitis. Am J Kidney Dis 36:498-506
16. Choi IJ, Jeong HJ, Lee HY, Kim PK, Lee JS, Han DS (1990) Significance of mesangial IgA deposition in minimal change nephrotic syndrome: A study of 60 cases. Yonsei Med J 31:258-263
17. Habib R, Niaudet P (1994) Comparison between pre- and posttreatment renal biopsies in children receiving cyclosporine for idiopathic nephrosis. Clin Nephrol 42:141-146
18. Zachariae H, Kragballe K, Hansen HE, Marcussen N, Olsen S (1997) Renal biopsy findings in long-term cyclosporin treatment of psoriasis. Br J Dermatol 136:531-535
19. Scheinman JI, Trachtman H, Lin CY, Langman CB, Chan JC (1997) IgA nephropathy: To treat or not to treat? Nephron 75:251-258
20. Nolin L, Courteau M (1999) Management of IgA nephropathy: Evidence-based recommendations. Kidney Int 70:S56-S62
21. Barratt J, Feehally J (2006) Treatment of IgA nephropathy. Kidney Int 69:1934-1938
22. Harmankaya O, Ozturk Y, Basturk T, Obek A, Kilicarslan I (2002) Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria. Int Urol Nephrol 33:167-171
23. Cattran DC (1991) Current status of cyclosporin A in the treatment of membranous, IgA and membranoproliferative glomerulonephritis. Clin Nephrol 35:S43-S47
24. Mihatsch MJ, Thiel G, Ryffel B (1988) Histopathology of cyclosporine nephrotoxicity. Transplant Proc 20[Suppl 3]:759-771
25. Franceschini N, Alpers CE, Bennett WM, Andoh TF (1998) Cyclosporine arteriolopathy: Effects of drug withdrawal. Am J Kidney Dis 32:247-253
26. Hamahira K, Iijima K, Tanaka R, Nakamura H, Yoshikawa N (2001) Recovery from cyclosporine-associated arteriolopathy in childhood nephrotic syndrome. Pediatr Nephrol 16:723-727
27. Sarioǧlu S, Celik A, Erşen A, Uçer I, Saǧlam F, Camsari T, Gülay H (2008) Vascular endothelial growth factor expression and vascularity in renal allograft biopsies. Transplant Proc 40:178-180
28. Atakan A, Arikan H, Macunluoglu B, Tuglular S, Ulfer G, Cakalagaoglu F, Ozener C, Akoglu E (2008) Renal protective effects of leukotriene receptor blockers in an experimental model of cyclosporine nephrotoxicity. Transplant Proc 40:279-284
29. Namikoshi T, Satoh M, Horike H, Fujimoto S, Arakawa S, Sasaki T, Kashihara N (2006) Implication of peritubular capillary loss and altered expression of vascular endothelial growth factor in IgA nephropathy. Nephron Physiol 102:9-16
30. Heller F, Lindenmeyer MT, Cohen CD, Brandt U, Draganovici D, Fischereder M, Kretzler M, Anders HJ, Sitter T, Mosberger I, Kerjaschki D, Regele H, Schlöndorff D, Segerer S (2007) The contribution of B cells to renal interstitial inflammation. Am J Pathol 170:457-468